Stocks and Investing
Stocks and Investing
Wed, July 10, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Tue, July 9, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Joshua Spector Upgraded (CC) to Strong Buy and Increased Target to $30 on, Jul 9th, 2024
Joshua Spector of UBS, Upgraded "The Chemours Company" (CC) to Strong Buy and Increased Target from $28 to $30 on, Jul 9th, 2024.
Joshua has made no other calls on CC in the last 4 months.
There are 3 other peers that have a rating on CC. Out of the 3 peers that are also analyzing CC, 2 agree with Joshua's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- John Roberts of "Mizuho" Initiated at Hold and Held Target at $25 on, Friday, June 7th, 2024
- Michael Leithead of "Barclays" Maintained at Hold with Decreased Target to $30 on, Tuesday, April 2nd, 2024
This is the rating of the analyst that currently disagrees with Joshua
- John McNulty of "BMO Capital" Upgraded from Hold to Buy and Increased Target to $34 on, Tuesday, April 9th, 2024
Contributing Sources